Kullberg, Bart Jan

The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans

Cheng, S.-C., van de Veerdonk, F. L., Lenardon, M., Stoffels, M., Plantinga, T., Smeekens, S., Rizzetto, L., Mukaremera, L., Preechasuth, K., Cavalieri, D., et al. (2011) · Journal of Leukocyte Biology

Antifungal resistance and susceptibilityInflammasome and immune disorders

Cited by 191

Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis

Guery, B. P., Arendrup, M. C., Auzinger, G., Azoulay, É., Borges Sá, M., Johnson, E. M., Müller, E., Putensen, C., Rotstein, C., Sganga, G., et al. (2009) · Intensive Care Medicine

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 173

Host–microbe interactions: innate pattern recognition of fungal pathogens

van de Veerdonk, F. L., Kullberg, B. J., van der Meer, J. W., Gow, N. A., & Netea, M. G. (2008) · Current Opinion in Microbiology

Immune Response and InflammationAntifungal resistance and susceptibility

Cited by 169

Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris

Bruno, M., Kersten, S., Bain, J. M., Jaeger, M., Rosati, D., Kruppa, M. D., Lowman, D. W., Rice, P. J., Graves, B., Ma, Z., et al. (2020) · Nature Microbiology

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 145

Role of dectin-2 for host defense against systemic infection with Candida glabrata

Ifrim, D. C., Bain, J. M., Reid, D. M., Oosting, M., Verschueren, I., Gow, N. A. R., van Krieken, J. H., Brown, G. D., Kullberg, B.-J., Joosten, L. A. B., et al. (2014) · Infection and Immunity

Antifungal resistance and susceptibilityImmune Response and Inflammation

Cited by 117

Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1

Kullberg, B. J., van 't Wout, J. W., & van Furth, R. (1990) · Infection and Immunity

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 105

Early treatment of candidemia in adults: a review

Ostrosky-Zeichner, L., Kullberg, B. J., Bow, E. J., Hadley, S., León, C., Nucci, M., Patterson, T. F., & Perfect, J. R. (2011) · Medical Mycology

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 97

Genetic variation of innate immune genes in HIV-infected african patients with or without oropharyngeal candidiasis

Plantinga, T. S., Hamza, O. J. M., Willment, J. A., Ferwerda, B., van de Geer, N. M. D., Verweij, P. E., Matee, M. I. N., Banahan, K., O'Neill, L. A. J., Kullberg, B.-J., et al. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes

Antifungal resistance and susceptibilityImmune Response and Inflammation

Cited by 53

Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure

van de Veerdonk, F. L., Kullberg, B. J., Verschueren, I. C., Hendriks, T., van der Meer, J. W. M., Joosten, L. A. B., & Netea, M. G. (2010) · Shock

Antifungal resistance and susceptibilitySepsis Diagnosis and Treatment

Cited by 49

Duration of antifungal treatment and development of delayed complications in patients with candidaemia

Oude Lashof, A. M. L., Donnelly, J. P., Meis, J. F. G. M., van der Meer, J. W. M., & Kullberg, B. J. (2003) · European Journal of Clinical Microbiology and Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 49

147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial

Pappas, P., Kullberg, B. J., Vazquez, J. A., Oren, I., Rahav, G., Aoun, M., Bulpa, P., Ben-Ami, R., Ferrer, R., McCarty, T. P., et al. (2020) · Open Forum Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 17